Oncoinvent ASA

Director's Dealing • Dec 22, 2025

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Øystein Soug
2	Reason for the notification
a)	Position/status	CEO
b)	Initial	Initial notification
	notification/Amendment
3	Details of issuer
a)	Name	Oncoinvent ASA
b)	LEI	213800TYYFXKYF3V2A23
4			Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of
		transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial		Options with shares in Oncoinvent ASA (ISIN: NO0013251173) as underlying.
	instrument, type of	Replacement of option program from Oncoinvent before merger.
	instrument
	Identification code
b)	Nature of the transaction	Receipt of share options
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 0	1 106 466
d)	Aggregated information	1 106 466
	— Aggregated volume
	— Price	NOK 0
e)	Date of the transaction	2025-12-22
f)	Place of the transaction	Outside a trading venue - XOFF

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Tore Kvam
2	Reason for the notification
a)	Position/status	CFO
b)	Initial	Initial notification
	notification/Amendment
3	Details of issuer
a)	Name	Oncoinvent ASA
b)	LEI	213800TYYFXKYF3V2A23
4		transaction; (iii) each date; and (iv) each place where transactions have been conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of
a)	Description of the financial instrument, type of instrument Identification code	Options with shares in Oncoinvent ASA (ISIN: NO0013251173) as underlying. Replacement of option program from Oncoinvent before merger.
b)	Nature of the transaction	Receipt of share options
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 0	383 655
d)	Aggregated information — Aggregated volume — Price	383 655 NOK 0
e)	Date of the transaction	2025-12-22
f)	Place of the transaction	Outside a trading venue - XOFF

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Kari Myren
2	Reason for the notification
a)	Position/status	CMO
b)	Initial notification/Amendment	Initial notification
3	Details of issuer
a)	Name	Oncoinvent ASA
b)	LEI	213800TYYFXKYF3V2A23
4		transaction; (iii) each date; and (iv) each place where transactions have been conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of
a)	Description of the financial instrument, type of instrument Identification code	Options with shares in Oncoinvent ASA (ISIN: NO0013251173) as underlying. Replacement of option program from Oncoinvent before merger.
b)	Nature of the transaction	Receipt of share options
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 0	358 399
d)	Aggregated information — Aggregated volume — Price	358 399 NOK 0
e)	Date of the transaction	2025-12-22
f)	Place of the transaction	Outside a trading venue - XOFF

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Anne-Kirsti Aksnes
2	Reason for the notification
a)	Position/status	CCO
b)	Initial notification/Amendment	Initial notification
3	Details of issuer
a)	Name	Oncoinvent ASA
b)	LEI	213800TYYFXKYF3V2A23
4		transaction; (iii) each date; and (iv) each place where transactions have been conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of
a)	Description of the financial instrument, type of instrument Identification code	Options with shares in Oncoinvent ASA (ISIN: NO0013251173) as underlying. Replacement of option program from Oncoinvent before merger.
b)	Nature of the transaction	Receipt of share options
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 0	336 751
d)	Aggregated information — Aggregated volume — Price	336 751 NOK 0
e)	Date of the transaction	2025-12-22
f)	Place of the transaction	Outside a trading venue - XOFF

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Gro E. Hjellum
2	Reason for the notification
a)	Position/status	COO
b)	Initial	Initial notification
	notification/Amendment
3	Details of issuer
a)	Name	Oncoinvent ASA
b)	LEI	213800TYYFXKYF3V2A23
4			Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of
		transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial		Options with shares in Oncoinvent ASA (ISIN: NO0013251173) as underlying.
	instrument, type of	Replacement of option program from Oncoinvent before merger.
	instrument Identification code
b)	Nature of the transaction	Receipt of share options
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 0	334 826
d)	Aggregated information	334 826
	— Aggregated volume	NOK 0
	— Price
e)	Date of the transaction	2025-12-22
f)	Place of the transaction	Outside a trading venue - XOFF

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Kristine Lofthus
2	Reason for the notification
a)	Position/status	CPO
b)	Initial notification/Amendment	Initial notification
3	Details of issuer
a)	Name	Oncoinvent ASA
b)	LEI	213800TYYFXKYF3V2A23
4			Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of
		transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Options with shares in Oncoinvent ASA (ISIN: NO0013251173) as underlying. Replacement of option program from Oncoinvent before merger.
b)	Nature of the transaction	Receipt of share options
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 0	329 534
d)	Aggregated information	329 534
	— Aggregated volume	NOK 0
	— Price
e)	Date of the transaction	2025-12-22
f)	Place of the transaction	Outside a trading venue - XOFF

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Stian Brekke
2	Reason for the notification
a)	Position/status	Head of Regulatory
b)	Initial notification/Amendment	Initial notification
3	Details of issuer
a)	Name	Oncoinvent ASA
b)	LEI	213800TYYFXKYF3V2A23
4		transaction; (iii) each date; and (iv) each place where transactions have been conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of
a)	Description of the financial instrument, type of instrument Identification code	Options with shares in Oncoinvent ASA (ISIN: NO0013251173) as underlying. Replacement of option program from Oncoinvent before merger.
b)	Nature of the transaction	Receipt of share options
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 0	328 813
d)	Aggregated information — Aggregated volume — Price	328 813 NOK 0
e)	Date of the transaction	2025-12-22
f)	Place of the transaction	Outside a trading venue - XOFF

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Anne Cecilie Alvik
2	Reason for the notification
a)	Position/status	Head of Regulatory
b)	Initial notification/Amendment	Initial notification
3	Details of issuer
a)	Name	Oncoinvent ASA
b)	LEI	213800TYYFXKYF3V2A23
4		transaction; (iii) each date; and (iv) each place where transactions have been conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of
a)	Description of the financial instrument, type of instrument Identification code	Options with shares in Oncoinvent ASA (ISIN: NO0013251173) as underlying. Replacement of option program from Oncoinvent before merger.
b)	Nature of the transaction	Receipt of share options
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 0	328 452
d)	Aggregated information — Aggregated volume — Price	328 452 NOK 0
e)	Date of the transaction	2025-12-22
f)	Place of the transaction	Outside a trading venue - XOFF

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Gillies O'Bryan-Tear
2	Reason for the notification
a)	Position/status	Board members
b)	Initial notification/Amendment	Initial notification
3	Details of issuer
a)	Name	Oncoinvent ASA
b)	LEI	213800TYYFXKYF3V2A23
4		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Options with shares in Oncoinvent ASA (ISIN: NO0013251173) as underlying. Replacement of option program from Oncoinvent before merger.
b)	Nature of the transaction	Receipt of share options
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 0	353 722
d)	Aggregated information — Aggregated volume — Price	353 722 NOK 0
e)	Date of the transaction	2025-12-22
f)	Place of the transaction	Outside a trading venue - XOFF

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Kari Grønås
2	Reason for the notification
a)	Position/status	Board member
b)	Initial notification/Amendment	Initial notification
3	Details of issuer
a)	Name	Oncoinvent ASA
b)	LEI	213800TYYFXKYF3V2A23
4		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Options with shares in Oncoinvent ASA (ISIN: NO0013251173) as underlying. Replacement of option program from Oncoinvent before merger.
b)	Nature of the transaction	Receipt of share options
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 0	165 168
d)	Aggregated information — Aggregated volume — Price	165 168 NOK 0
e)	Date of the transaction	2025-12-22
f)	Place of the transaction	Outside a trading venue - XOFF

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Hilde Steineger
2	Reason for the notification
a)	Position/status	Board member
b)	Initial notification/Amendment	Initial notification
3	Details of issuer
a)	Name	Oncoinvent ASA
b)	LEI	213800TYYFXKYF3V2A23
4		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Options with shares in Oncoinvent ASA (ISIN: NO0013251173) as underlying. Replacement of option program from Oncoinvent before merger.
b)	Nature of the transaction	Receipt of share options
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 0	165 168
d)	Aggregated information — Aggregated volume — Price	165 168 NOK 0
e)	Date of the transaction	2025-12-22
f)	Place of the transaction	Outside a trading venue - XOFF

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Orlando Oliveira
2	Reason for the notification
a)	Position/status	Board member
b)	Initial notification/Amendment	Initial notification
3	Details of issuer
a)	Name	Oncoinvent ASA
b)	LEI	213800TYYFXKYF3V2A23
4		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Options with shares in Oncoinvent ASA (ISIN: NO0013251173) as underlying. Replacement of option program from Oncoinvent before merger.
b)	Nature of the transaction	Receipt of share options
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 0	165 168
d)	Aggregated information — Aggregated volume — Price	165 168 NOK 0
e)	Date of the transaction	2025-12-22
f)	Place of the transaction	Outside a trading venue - XOFF

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Johan Häggblad
2	Reason for the notification
a)	Position/status	Board member
b)	Initial	Initial notification
	notification/Amendment
3	Details of issuer
a)	Name	Oncoinvent ASA
b)	LEI	213800TYYFXKYF3V2A23
4		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of
		transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial	Options with shares in Oncoinvent ASA (ISIN: NO0013251173) as underlying.
	instrument, type of	Replacement of option program from Oncoinvent before merger.
	instrument Identification code
b)	Nature of the transaction	Receipt of share options
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 0	95 012
d)	Aggregated information	95 012
	— Aggregated volume	NOK 0
	— Price
e)	Date of the transaction	2025-12-22
f)	Place of the transaction	Outside a trading venue - XOFF